|
Jubilant Pharmova Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
14943.76 Cr.
|
P/BV
|
2.09
|
Book Value (Rs.)
|
448.85
|
|
52 Week High/Low (Rs.)
|
1185/786
|
FV/ML
|
1/1
|
P/E(X)
|
37.50
|
|
Bookclosure
|
24/07/2026
|
EPS (Rs.)
|
25.02
|
Div Yield (%)
|
0.53
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 8225.10 | 7192.10 | 6644.80 | 6219.30 | 6059.17 |
| Other Operating Revenues | 54.50 | 42.40 | 58.10 | 62.43 | 71.00 |
| Total Operating Revenues | 8279.60 | 7234.50 | 6702.90 | 6281.73 | 6130.16 |
| | | | | | |
| Other Income | 66.00 | 56.80 | 68.70 | 38.33 | 11.29 |
| Total Revenue | 8345.60 | 7291.30 | 6771.60 | 6320.06 | 6141.45 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 2320.30 | 1985.30 | 1821.30 | 1666.41 | 1348.70 |
| Purchase Of Stock-In Trade | 313.10 | 297.10 | 241.20 | 252.22 | 201.62 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 10.90 | 34.60 | 78.20 | -40.70 | -62.32 |
| Employee Benefit Expenses | 2700.60 | 2267.90 | 2216.00 | 2166.02 | 2043.39 |
| Finance Costs | 211.80 | 240.30 | 272.30 | 188.20 | 145.49 |
| Depreciation And Amortisation Expenses | 440.40 | 368.60 | 381.90 | 554.03 | 381.70 |
| Other Expenses | 1674.90 | 1475.90 | 1445.40 | 1461.53 | 1442.44 |
| Total Expenses | 7672.00 | 6669.70 | 6456.30 | 6247.71 | 5501.02 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 673.60 | 621.60 | 315.30 | 72.35 | 640.43 |
| | | | | | |
| Exceptional Items | -59.20 | 359.50 | -168.90 | -56.82 | 0.00 |
| Profit/Loss Before Tax | 614.40 | 981.10 | 146.40 | 15.53 | 640.43 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 160.70 | 213.20 | 202.60 | 181.09 | 172.55 |
| Deferred Tax | 55.90 | -68.90 | -104.80 | -88.42 | 44.88 |
| Total Tax Expenses | 216.60 | 144.30 | 97.80 | 92.66 | 217.43 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 397.80 | 836.80 | 48.60 | -77.13 | 423.00 |
| | | | | | |
| Profit/Loss From Continuing Operations | 397.80 | 836.80 | 48.60 | -77.13 | 423.00 |
| | | | | | |
| Profit/Loss For The Period | 397.80 | 836.80 | 48.60 | -77.13 | 423.00 |
| | | | | | |
| Minority Interest | 1.00 | 3.10 | 4.40 | 3.90 | 0.92 |
| Share Of Profit/Loss Of Associates | -0.30 | -0.50 | 24.10 | 12.25 | -9.98 |
| Consolidated Profit/Loss After MI And Associates | 398.50 | 839.40 | 77.10 | -60.98 | 413.94 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 25.15 | 52.99 | 4.87 | -3.83 | 26.00 |
| Diluted EPS (Rs.) | 25.08 | 52.99 | 4.86 | -3.83 | 26.00 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 79.60 | 79.60 | 79.60 | 79.64 | 79.64 |
